Article
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy
Neuro-Oncology Advances
Publication Date
9-13-2022
Content Type
application/pdf
PubMed ID:
36382108
Citation Information
Gardner, S. L., Tarapore, R. S., Allen, J., McGovern, S. L., Zaky, W., Odia, Y., Daghistani, D., Diaz, Z., Hall, M. D., Khatib, Z., Koschmann, C., Cantor, E., Kurokawa, R., MacDonald, T. J., Aguilera, D., Vitanza, N. A., Mueller, S., Kline, C., Lu, G., Allen, J. E., … Khatua, S. (2022). Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy. Neuro-oncology advances, 4(1), vdac143. https://doi.org/10.1093/noajnl/vdac143